Traws Pharma, Inc. — Director's Dealing 2023

Aug 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2023-08-10

Reporting Person: MARINO JAMES J (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-10	Stock Option (right to purchase)	$1.02	A	66468	Acquired	2033-08-10	Common Stock (66468)	Direct

Footnotes

F1: These options vest 100% on the first anniversary of the grant date.